Rate of Non-copers to Non-surgical ACL Treatment After 3 Months of Rehabilitation
Launched by VEJLE HOSPITAL · Apr 14, 2021
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a specific screening tool can help identify patients who may need surgery after experiencing an anterior cruciate ligament (ACL) injury, particularly those who may not improve enough with standard rehabilitation. The goal is to see if this tool can accurately predict which patients will continue to struggle with their injury after three months of rehabilitation.
If you or a loved one has had a recent ACL injury (within the last six months) and is over 18 years old, you might be eligible to participate in this study. However, those with more complicated injuries, such as multiple ligament tears or significant damage to cartilage, will not be included. Participants will go through the usual rehabilitation process and will be monitored to see how well they recover. This study is currently recruiting participants, so if you're interested, it could be a great opportunity to contribute to understanding ACL injuries better.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • unilateral primary ACL injury
- • Index injury no older than 6 months
- Exclusion Criteria:
- • Multiligament rupture
- • Large cartillage or meniscus injuries
- • Scheduled ACL reconstruction within 3 months
About Vejle Hospital
Vejle Hospital is a leading healthcare institution in Denmark, dedicated to advancing medical research and enhancing patient care through innovative clinical trials. With a focus on multidisciplinary collaboration, Vejle Hospital leverages its state-of-the-art facilities and experienced research teams to conduct rigorous studies across various therapeutic areas. Committed to ethical standards and patient safety, the hospital aims to contribute valuable insights to the medical community, ultimately improving treatment outcomes and healthcare practices. Through its clinical trial initiatives, Vejle Hospital strives to foster a culture of scientific excellence and drive advancements in health and medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vejle, Region Of Southern Denmark, Denmark
Patients applied
Trial Officials
Claus Varnum, ph.d.
Study Director
Vejle Hosptal
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials